Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 811,986 | 586,395 | 618,696 | 938,944 | 631,908 |
| Marketable Securities | 25,000 | 21,900 | 18,800 | 16,100 | 13,200 |
| Receivables | 31,474 | 27,511 | 29,316 | 28,901 | 27,743 |
| Other current assets | 896,110 | 790,005 | 861,279 | 865,592 | 847,390 |
| TOTAL | $1,764,570 | $1,425,811 | $1,528,091 | $1,849,537 | $1,520,241 |
| Non-Current Assets | |||||
| PPE Net | 16,192,720 | 16,542,350 | 16,208,480 | 15,763,670 | 15,134,290 |
| Investments And Advances | 875,991 | 845,767 | 880,280 | 722,850 | 658,343 |
| Intangibles | 923,535 | 924,634 | 924,634 | 924,634 | 924,634 |
| Other Non-Current Assets | 62,954 | 76,859 | 79,296 | 86,586 | 85,493 |
| TOTAL | $18,055,200 | $18,389,610 | $18,092,690 | $17,497,740 | $16,802,760 |
| Total Assets | $19,819,770 | $19,815,410 | $19,620,780 | $19,347,280 | $18,323,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 380,000 | 380,000 | 380,000 | 380,000 | 999,436 |
| Accounts payable and accrued liabilities | 126,846 | 112,900 | 92,229 | 118,637 | 118,406 |
| Accrued Expenses | 107,766 | 25,302 | 110,818 | 29,044 | 85,609 |
| Other current liabilities | 16,316 | 17,480 | 53,164 | 3,121 | 3,075 |
| TOTAL | $630,928 | $535,682 | $636,211 | $530,802 | $1,206,526 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,581,892 | 8,576,443 | 8,570,917 | 8,565,735 | 7,003,063 |
| Other Non-Current Liabilities | 757,634 | 592,891 | 557,005 | 473,888 | 550,012 |
| TOTAL | $9,403,129 | $9,342,900 | $9,269,630 | $9,195,617 | $7,613,534 |
| Total Liabilities | $10,034,060 | $9,878,582 | $9,905,841 | $9,726,419 | $8,820,060 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 575,832 | 576,857 | 577,238 | 583,174 |
| Common Shares | 108 | 108 | 106 | 107 | 107 |
| Retained earnings | 2,459,089 | 2,507,091 | 2,356,318 | 2,304,314 | 2,222,750 |
| Other shareholders' equity | 2,953,251 | 3,048,578 | 3,238,427 | 3,206,902 | 3,155,418 |
| TOTAL | $9,785,714 | $9,936,833 | $9,714,939 | $9,620,861 | $9,502,940 |
| Total Liabilities And Equity | $19,819,774 | $19,815,415 | $19,620,780 | $19,347,280 | $18,323,000 |